{"topic_id":"cn_moa_ann1038_new_veterinary_drugs_pet","category":"cn-2026-approvals","context":"---\ntopic_id: cn_moa_ann1038_new_veterinary_drugs_pet\ncategory: cn-2026-approvals\ntitle: \"农业农村部公告第1038号 (MOA Announcement No. 1038) — 6 New Veterinary Drugs Including Cat Triple Vaccine and Pet Formulations (2026-07-06)\"\nlang: en\nsource: ivdc-announcement-1038-attach-20260707.pdf\ndate_parsed: 2026-07-21\ntokens_estimated: 1100\nverification:\n  method: substring_match\n  claims: 7\n  passed: 7\n  date: 2026-07-21\nsource_document: \"China MOA Announcement / 农业农村部公告 (2026 approvals) — 公告第1038号\"\ncitation:\n  authority: \"China MOA — Announcement & Gazette series\"\n  title: \"农业农村部公告第1038号 (MOA Announcement No. 1038) — 6 New Veterinary Drugs Including Cat Triple Vaccine and Pet Formulations (2026-07-06)\"\n  url: \"\"\n  retrieved: \"2026-07-21\"\n  ref: \"公告第1038号\"\n  doc_type: \"official PDF\"\n  needs_review: true\nauthority_tier: T1\nauthority_tier_basis: \"T1:cn-gov\"\nauthority_tier_date: 2026-08-04\n---\n\n# MOA Announcement No. 1038 — 6 New Veterinary Drugs Including Cat Triple Vaccine and Pet Formulations (2026-07-06)\n\n**MOA Announcement No. 1038** (农业农村部公告第1038号) was issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China on **2026年7月6日** (July 6, 2026), promulgated pursuant to the *Regulations on the Administration of Veterinary Drugs* (《兽药管理条例》) and the *Measures for the Registration of Veterinary Drugs* (《兽药注册办法》).\n\nThe announcement approves **6 drug products as new veterinary drugs** (新兽药), issues New Veterinary Drug Registration Certificates (《新兽药注册证书》), and publishes product quality standards, process specifications, package inserts, and labels, effective from the date of promulgation. It also covers 8 veterinary drug product registrations, 4 change registrations, and associated documentation.\n\n> Source: Ministry of Agriculture and Rural Affairs, *Announcement No. 1038* (农业农村部公告第1038号), 2026-07-06.\n\n## Annex 1 — New Veterinary Drug Registration Catalogue (附件1 新兽药注册目录)\n\n### 1. Chlorhexidine Acetate Solution (醋酸氯己定溶液) — pet topical drug (宠物用外用药)\n\n| Field | Detail |\n|---|---|\n| Class (类别) | Category 3 (三类) |\n| Registration certificate (新兽药注册证书号) | （2026）新兽药证字66号 |\n| Monitoring period (监测期) | 3 years (3年) |\n| Research units (研制单位) | 青岛农业大学、青岛康地恩动物药业有限公司、青岛诺安百特生物技术有限公司 et al. (10 units total) |\n\n> Source text: `醋酸氯己定溶液 / 青岛农业大学... / 三类 / （2026）新兽药证字66号 / 3年 / /`\n\n**Package insert excerpt (package insert, PDF pp. 1–2):**\n- **Indications (适应症):** 用于犬皮肤、创面及黏膜消毒 (For disinfection of dog skin, wounds and mucous membranes)\n- **Usage and dosage (用法用量):** 外用：适量，喷于患处。一日2次，连用14日，或遵医嘱。 (External use: as appropriate, spray on the affected area. Twice daily for 14 consecutive days, or as directed by a veterinarian.)\n- **Adverse reactions (不良反应):** 偶见过敏反应，如接触性皮炎等。 (Occasional allergic reactions such as contact dermatitis.)\n- **Specification (规格):** 100ml∶1g\n- **Shelf life (有效期):** 36 months (36个月)\n- **Storage (贮藏):** 密闭，在凉暗处保存。 (Sealed, stored in a cool and dark place.)\n\n### 2. Huangsang Qingfei San (黄桑清肺散) — veterinary use (兽用)\n\n| Field | Detail |\n|---|---|\n| Class (类别) | Category 3 (三类) |\n| Registration certificate (新兽药注册证书号) | （2026）新兽药证字67号 |\n| Monitoring period (监测期) | 3 years (3年) |\n\n> Source text: `黄桑清肺散 / 南京农业大学、山东益远药业有限公司... / 三类 / （2026）新兽药证字67号 / 3年 / /`\n\n### 3. Porcine Circovirus Type 2 Baculovirus-Vector Inactivated Vaccine (SL08 Strain) (猪圆环病毒2型杆状病毒载体灭活疫苗（SL08株）)\n\n| Field | Detail |\n|---|---|\n| Class (类别) | Category 3 (三类) |\n| Registration certificate (新兽药注册证书号) | （2026）新兽药证字68号 |\n| Monitoring period (监测期) | 3 years (3年) |\n| Research unit (研制单位) | 齐鲁动物保健品有限公司 |\n\n### 4. Newcastle Disease, Avian Influenza (H9 Subtype), Fowl Adenovirus (Group I Type 4), Infectious Bursal Disease Combined Inactivated Vaccine (鸡新城疫、禽流感（H9亚型）、禽腺病毒病（I群4型）、传染性法氏囊病四联灭活疫苗)\n\n| Field | Detail |\n|---|---|\n| Class (类别) | Category 3 (三类) |\n| Registration certificate (新兽药注册证书号) | （2026）新兽药证字69号 |\n| Research unit (研制单位) | 青岛易邦生物工程有限公司 |\n\n### 5. Feline Rhinotracheitis, Calicivirus, Panleukopenia Combined Inactivated Vaccine (WX+SH14+0918 Strains) (猫鼻气管炎、猫杯状病毒病、猫泛白细胞减少症三联灭活疫苗（WX株+SH14株+0918株）) — pet cat vaccine (宠物用猫疫苗)\n\n| Field | Detail |\n|---|---|\n| Class (类别) | Category 3 (三类) |\n| Registration certificate (新兽药注册证书号) | （2026）新兽药证字70号 |\n| Monitoring period (监测期) | 3 years (3年) |\n| Research units (研制单位) | 中国农业科学院上海兽医研究所、唐山怡安生物工程有限公司、哈药集团生物疫苗有限公司 |\n\n**Package insert excerpt (package insert, PDF pp. 5–8):**\n- **Generic name (通用名称):** 猫鼻气管炎、猫杯状病毒病、猫泛白细胞减少症三联灭活疫苗（WX株+SH14株+0918株）\n- **Per 1.0 ml (1 dose) vaccine contains (每1.0ml（含1头份）疫苗中含):**\n  - Inactivated feline herpesvirus type 1, WX strain 10⁷·⁰ TCID₅₀ (灭活猫疱疹病毒1型 WX株 10⁷·⁰ TCID₅₀)\n  - Feline calicivirus, SH14 strain 10⁸·⁰ TCID₅₀ (猫杯状病毒 SH14株 10⁸·⁰ TCID₅₀)\n  - Feline parvovirus, 0918 strain 10⁴·⁰ TCID₅₀ (猫细小病毒 0918株 10⁴·⁰ TCID₅₀)\n- **Action and use (作用与用途):** 用于预防猫鼻气管炎、猫杯状病毒病和猫泛白细胞减少症。免疫产生期为二免后10日，免疫期为12个月。 (Used to prevent feline rhinotracheitis, calicivirus disease and panleukopenia. Immunity develops 10 days after the second vaccination; immunity period is 12 months.)\n- **Usage and dosage (用法与用量):** 皮下注射。8周龄以上健康猫首免，每只1.0ml（含1头份），21～28日后加强免疫1.0ml，以后每年加强免疫一次。 (Subcutaneous injection. First vaccination for healthy cats over 8 weeks of age, 1.0 ml (1 dose) each, booster 1.0 ml 21–28 days later, then once yearly.)\n\n### 6. Gabapentin Oral Solution (加巴喷丁内服溶液) — pet use (宠物用)\n\n| Field | Detail |\n|---|---|\n| Class (类别) | Category 4 (四类) |\n| Registration certificate (新兽药注册证书号) | （2026）新兽药证字71号 |\n| Monitoring period (监测期) | 3 years (3年) |\n| Note (备注) | Subject to veterinary prescription-drug management (纳入兽用处方药管理) |\n| Research units (研制单位) | 山东爱士津生物技术有限公司、烟台爱士津动物保健品有限公司、山东爱士津生物制药有限公司 |\n\n## Annex 2 — Veterinary Drug Change Registration Catalogue (附件2 兽药变更注册目录)\n\nSelected notable changes (变更注册):\n- **复方二氯苯醚菊酯吡丙醚滴剂 (Compound Diclorophenyl Ether Pyriproxyfen Drops):** validity period changed from \"24 months\" (24个月) to \"36 months\" (36个月) (original standard source: MOA Announcement No. 917, 农业农村部公告第917号)\n- **盐酸克林霉素内服溶液 (Clindamycin Hydrochloride Oral Solution):** validity period changed from \"36 months, 28 days after opening\" (36个月，开启后有效期为28日) to \"48 months, 28 days after opening\" (48个月，开启后有效期为28日)\n\n## Annex 5 — Package Inserts and Labels (附件5 说明书和标签)\n\nThe attachment PDF includes full package inserts for:\n1. 醋酸氯己定溶液 (Chlorhexidine Acetate Solution) (pp. 1–4, pet topical drug / 宠物用外用药, for disinfection of dog skin/wounds/mucous membranes / 用于犬皮肤/创面/黏膜消毒)\n2. 加巴喷丁内服溶液 (Gabapentin Oral Solution) (pp. 9+, pet use / 宠物用, subject to veterinary prescription-drug management / 纳入兽用处方药管理)\n\n---\n\n**Source:** `pdf-raw/cn-approvals/ivdc-announcement-1038-attach-20260707.pdf` (521 KB) + `pdf-raw/cn-approvals/ivdc-announcement-1038-20260707.html` · 农业农村部公告第1038号 (2026-07-06)\n","sources":["China MOA — Announcement & Gazette series — 农业农村部公告第1038号 (MOA Announcement No. 1038) — 6 New Veterinary Drugs Including Cat Triple Vaccine and Pet Formulations (2026-07-06) (retrieved 2026-07-21)"],"source":{"authority":"China MOA — Announcement & Gazette series","title":"农业农村部公告第1038号 (MOA Announcement No. 1038) — 6 New Veterinary Drugs Including Cat Triple Vaccine and Pet Formulations (2026-07-06)","url":"http://www.moa.gov.cn/","retrieved":"2026-07-21","ref":"公告第1038号","doc_type":"official PDF","source_document":"China MOA Announcement / 农业农村部公告 (2026 approvals) — 公告第1038号","verification_file":"ivdc-announcement-1038-attach-20260707.pdf"},"source_document":"China MOA Announcement / 农业农村部公告 (2026 approvals) — 公告第1038号","source_file":"ivdc-announcement-1038-attach-20260707.pdf","trust":{"authority_tier":"T1","fidelity":"verbatim","license":null,"display_grade":"A"},"tokens_estimated":1100,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}